Engrail Therapeutics
Precision Neuroscience. Transformational Therapies.
San Diego, United States · Founded 2019 · $221.0M raised
- Headquarters
- San Diego, California
- Employees
- 11–50
- Founded
- 2019
- Business Model
- B2B
- Website
- engrail.com
- Total Funding
- $221.0M
- Last Round
- $157.0M Series BMar 2024
- Rounds
- 3
About
Engrail Therapeutics is a clinical-stage pharmaceutical company focused on developing precision-targeted neuroscience therapies for neuropsychiatric and neurodevelopmental diseases. Its pipeline includes ENX-102 (GABA-A PAM for generalized anxiety disorder) and ENX-104 (for major depressive disorder with anhedonia), both in Phase 2 trials. The company raised a $157M Series B in 2024 to advance its programs.
Summary
Engrail Therapeutics is a Biotech company based in San Diego, United States, founded in 2019. It has raised $221.0M in total across 3 rounds, most recently a $157.0M Series B round in Mar 2024. Investors include F-Prime Capital, Forbion Capital Partners and Shiv Chaudhary.
Tech & App Stack
3 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Sign up to view the funding chart
Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.
Mar 2024
Sign up to see all 3 rounds
Series A through Series B — per-round amounts, valuations, and who invested in each round.
Investors
Similar Companies
China's leading mRNA biotech company developing therapeutics for cancer and infectious diseases.
San Diego-based clinical stage biopharmaceutical company focused on the development of small mole...
Clinical-stage biopharmaceutical developing precision medicines targeting novel mechanisms to tre...
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...
Late-stage biopharma using single-molecule tracking, AI, and engineering to discover and develop ...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/engrail-therapeutics"><img src="https://indexed.vc/api/badge/company/engrail-therapeutics" alt="Engrail Therapeutics on Indexed.vc" width="260" height="76" /></a>